Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Tempest Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +24 vs. Q1 2021
- Shares held
- 1.84M
- +1.84M vs. Q1 2021
- Total value
- $20.5M
- +$20.5M vs. Q1 2021
- New holders
- 24
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.44M |
| Q1 2026 | 22 | $1.29M |
| Q4 2025 | 21 | $2.26M |
| Q3 2025 | 17 | $6.02M |
| Q2 2025 | 18 | $6.42M |
| Q1 2025 | 24 | $4.42M |
| Q4 2024 | 35 | $5.66M |
| Q3 2024 | 28 | $3.94M |
| Q2 2024 | 24 | $4.70M |
| Q1 2024 | 30 | $7.29M |
| Q4 2023 | 32 | $9.74M |
| Q3 2023 | 24 | $1.05M |
| Q2 2023 | 22 | $4.86M |
| Q1 2023 | 17 | $7.21M |
| Q4 2022 | 13 | $3.54M |
| Q3 2022 | 16 | $5.36M |
| Q2 2022 | 16 | $6.67M |
| Q1 2022 | 15 | $7.12M |
| Q4 2021 | 19 | $12.4M |
| Q3 2021 | 22 | $31.8M |
| Q2 2021 | 24 | $20.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 10 | $0 | 0.00% | +10 | New |
| Wells Fargo & Company | 8 | $0 | 0.00% | +8 | New |
| Baystate Wealth Management LLC | 5 | $0 | 0.00% | +5 | New |
| Atlas Private Wealth Advisors | 7 | $0 | 0.00% | +7 | New |
| UBS Group AG | 147 | $2.00K | 0.00% | +147 | New |
| Cutler Group LP | 333 | $3.00K | 0.00% | +333 | New |
| Tower Research Capital LLC (TRC) | 583 | $6.00K | 0.00% | +583 | New |
| Morgan Stanley | 726 | $8.00K | 0.00% | +726 | New |
| Bank of America Corp | 834 | $9.00K | 0.00% | +834 | New |
| Group One Trading, L.P. | 802 | $9.00K | 0.00% | +802 | New |
| BlackRock Inc. | 4,919 | $55.0K | 0.00% | +4,919 | New |
| Acadian Asset Management LLC | 8,643 | $96.0K | 0.00% | +8,643 | New |
| Boothbay Fund Management, LLC | 10,477 | $117.0K | 0.00% | +10,477 | New |
| Knott David M | 13,833 | $155.0K | 0.06% | +13,833 | New |
| Renaissance Technologies LLC | 26,867 | $300.0K | 0.00% | +26,867 | New |
| Vanguard Group Inc | 61,150 | $683.0K | 0.00% | +61,150 | New |
| Ikarian Capital, LLC | 89,865 | $1.00M | 0.18% | +89,865 | New |
| Maven Securities LTD | 106,628 | $1.20M | 0.13% | +106,628 | New |
| Monashee Investment Management LLC | 113,644 | $1.27M | 0.15% | +113,644 | New |
| NEA Management Company, LLC | 117,785 | $1.32M | 0.02% | +117,785 | New |
| FIL Ltd | 129,579 | $1.45M | 0.00% | +129,579 | New |
| Foresite Capital Management IV, LLC | 190,212 | $2.13M | 0.29% | +190,212 | New |
| Rock Springs Capital Management LP | 310,161 | $3.47M | 0.07% | +310,161 | New |
| FMR LLC | 647,898 | $7.24M | 0.00% | +647,898 | New |